The DOI matches its Crossref record, with a small difference in title or year; 9 of the 9 references it cites were found in a registry or an index.
An integrated national scale SARS-CoV-2 genomic surveillance network
Open accessAbstract
The Coronavirus Disease 2019 (COVID-19) Genomics UK Consortium (COG-UK) was launched in March, 2020, with £20 million support from UK Research and Innovation, the UK Department of Health and Social Care, and Wellcome Trust. The goal of this consortium is to sequence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for up to 230 000 patients, health-care workers, and other essential workers in the UK with COVID-19, which will help to enable the tracking of SARS-CoV-2 transmission, identify viral mutations, and integrate with health data to assess how the viral genome interacts with cofactors and consequences of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This yielded nearly identical results in our survival analysis compared with the analysis that uses the modelled p VOC described above (Fig. 2e).”
From Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 (2021) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0770-5 · Cited by 2,543
Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings
Fraser, C., Donnelly, C. A., Cauchemez, S., Hanage, W. P., Van Kerkhove, M. D., Hollingsworth, T. D., Griffin, J., Baggaley, R. F., Jenkins, H. E., Lyons, E. J., et al. (2009) · Science · doi:10.1126/science.1176062 · Cited by 1,909
Microreact: visualizing and sharing data for genomic epidemiology and phylogeography
Argimón, S., Abudahab, K., Goater, R. J. E., Fedosejev, A., Bhai, J., Glasner, C., Feil, E. J., Holden, M. T. G., Yeats, C. A., Grundmann, H., et al. (2016) · Microbial Genomics · doi:10.1099/mgen.0.000093 · Cited by 732
Phylodynamics of Infectious Disease Epidemics
Volz, E. M., Kosakovsky Pond, S. L., Ward, M. J., Leigh Brown, A. J., & Frost, S. D. W. (2009) · Genetics · doi:10.1534/genetics.109.106021 · Cited by 237
Connor, T. R., Loman, N. J., Thompson, S., Smith, A., Southgate, J., Poplawski, R., Bull, M. J., Richardson, E., Ismail, M., Thompson, S. E., et al. (2016) · Microbial Genomics · doi:10.1099/mgen.0.000086 · Cited by 207
A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology
Rambaut, A., Holmes, E. C., Hill, V., O’Toole, Á., McCrone, J., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.17.046086 · Cited by 158
Baillie, G. J., Galiano, M., Agapow, P., Myers, R. E., Chiam, R., Gall, A., Palser, A. L., Watson, S. J., Hedge, J., Underwood, A. P., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05347-11 · Cited by 115
Connor, T. R., Loman, N. J., Thompson, S., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/064451 · Cited by 99
Use of Whole-Genome Sequencing in the Investigation of a Nosocomial Influenza Virus Outbreak
Houlihan, C. F., Frampton, D., Ferns, R. B., Raffle, J., Grant, P. R., Reidy, M., Hail, L., Thomson, K. J., Mattes, F. M., Kozlakidis, Z., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy335 · Cited by 55
Cited by
Infectious disease in an era of global change
Baker, R. E., Mahmud, A. S., Miller, I. F., Rajeev, M., Rasambainarivo, F., Rice, B. L., Takahashi, S., Tatem, A. J., Wagner, C. E., Wang, L.-F., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00639-z · Cited by 2,059
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03470-x · Cited by 1,611
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006
The biological and clinical significance of emerging SARS-CoV-2 variants
Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00408-x · Cited by 1,009
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
CMMID COVID-19 Working Group, Davies, N. G., Jarvis, C. I., Edmunds, W. J., Jewell, N. P., Diaz-Ordaz, K., & Keogh, R. H. (2021) · Nature · doi:10.1038/s41586-021-03426-1 · Cited by 921
Metadata
- Authors
- consortiumcontact@cogconsortium.uk, C.-1. G. U. (.-U.
- Corresponding author
- COVID-19 Genomics UK (COG-UK) consortiumcontact@cogconsortium.uk
- Venue
- The Lancet Microbe
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 1
- Issue
- 3
- Pages
- e99-e100
- ISSN
- 2666-5247 (ISSN-L)
- PMC
- PMC7266609
- OpenAlex
- W3033301286
- Cited by
- 261
- References
- 9
- Citations by year
- 2026: 7 · 2025: 22 · 2024: 28 · 2023: 43 · 2022: 68 · 2021: 76 · 2020: 16
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Microbe (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Northumbria Research Link (Northumbria University) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Wellcome Trust
- UK Research and Innovation (MC_PC_19027)
- National Institute for Health and Care Research (NF-SI-0617-10176, RP-PG-0514-20018, ACF-2017-15-004, ACF-2020-04-004)
- Medical Research Council (1991596, MR/R015600/1, MC_PC_19012)
- Biotechnology and Biological Sciences Research Council (BBS/E/F/000PR10348, BBS/E/F/000PR10352)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, genomic surveillance, viral genome sequencing, viral mutations, healthcare workers, essential workers
- MeSH terms
- COVID-19, SARS-CoV-2, Humans, Genome, Viral, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An integrated national scale SARS-CoV-2 genomic surveillance network. https://app.cochat.ai/papers/10.1016/s2666-5247(20)30054-9
- The paper
- consortiumcontact@cogconsortium.uk, C.-1. G. U. (.-U. (2020). An integrated national scale SARS-CoV-2 genomic surveillance network. The Lancet Microbe. https://doi.org/10.1016/s2666-5247(20)30054-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.